| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
IDEAYA Biosciences (NASDAQ:IDYA) reported its Q4 earnings results on Tuesday, February 20, 2024 at 06:00 AM.
Here's what investors need to know about the announcement.
IDEAYA Biosciences missed estimated earnings by 10.64%, reporting an EPS of $-0.52 versus an estimate of $-0.47.
Revenue was down $99 thousand from the same period last year.
Last quarter the company beat on EPS by $0.03 which was followed by a 5.67% increase in the share price the next day.
Here's a look at IDEAYA Biosciences's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | -0.49 | -0.56 | -0.55 | -0.56 |
| EPS Actual | -0.46 | -0.50 | -0.49 | -0.50 |
| Revenue Estimate | 7.32M | 4.51M | 6.41M | 7.00M |
| Revenue Actual | 8.04M | 3.54M | 7.88M | 4.02M |
** Listen to the earnings announcement yourself by clicking here. **
To track all earnings releases for IDEAYA Biosciences visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: IDYA
